首页|低分子肝素治疗复发性流产的临床疗效及安全性

低分子肝素治疗复发性流产的临床疗效及安全性

扫码查看
目的 探讨在治疗复发性流产中应用低分子肝素的临床疗效及安全性。方法 本研究纳入所有病例均为2019年1月至2021年12月就诊于漯河市第一人民医院216例复发性流产患者,进行回顾性分析,将其按照治疗方法分为A组(108例,采用常规治疗措施)和B组(108例,采用低分子肝素联合常规治疗)。将2组患者治疗前后激素指标水平、凝血功能指标、足月生产率、流产率、早产率及不良反应发生情况进行对比。结果 治疗后2组患者血清激素指标水平均相较于治疗前上升,且B组患者上述指标相较于A组升高(t=8。499、15。076、6。422,P均<0。05);治疗后2组患者血小板计数、纤维蛋白原(FIB)均比治疗前下降,且B组患者上述指标比A组低,而治疗后2组患者活化部分凝血活酶时间(APTT)均比治疗前升高,且B组患者上述指标比A组升高(t=6。120、2。567、3。879,P均<0。05);B组患者足月生产率为53。7%相较于A组的32。4%升高,而流产率为23。2%则相较于A组的41。7%下降(x2=9。989、8。454,P均<0。05),2组患者早产率(25。9%、23。2%)比较,差异无统计学意义(x2=0。104,P>0。05);治疗过程中A组患者发生血小板减少7例,占6。5%;牙龈出血2例,占1。8%;淤斑3例,占2。8%,B组患者治疗过程中发生发生血小板减少11例,占10。2%;牙龈出血3例,占1。8%;淤斑4例,占3。7%,经对比,2组患者各项不良反应发生率之间差异无统计学意义(P>0。05)。结论 在复发性流产中应用低分子肝素,可提升足月生产率,降低流产率,使雌、孕激素水平提高,对凝血功能的改善起到促进作用,且不增加不良反应。
Clinical efficacy and safety of low molecular weight heparin in the treatment of recurrent abortion
Objective To investigate the clinical efficacy and safety of low molecular weight heparin in the treatment of recurrent abortion.Methods A total of 216 patients with recurrent miscarriage were included for retrospective analysis.All cases were from the First People's Hospital of Luohe City,selected from January 2019 to December 2021.According to different treatment methods,they were divided into group A(108 cases with conventional treatment)and group B(108 cases,treated with low molecular weight heparin combined with conventional treatment).The levels of hormone indexes,coagulation function indexes,full-term productivity,abortion rate,preterm birth rate and adverse reactions were compared between the two groups before and after treatment.Results After treatment,the levels of serum hormone indexes in both groups were increased compared with those before treatment,and those indexes in group B were increased compared with those in group A(t=8.499,15.076,6.422,all P<0.05).After treatment,the platelet count and Fibrinogen(FIB)in both groups were decreased compared with that before treatment,and the above indexes in group B were lower than those in group A.After treatment,the activated partial thromboplastin time(APTT)in both groups was higher than before treatment,and the above indexes in group B were higher than those in group A(t=6.120,2.567,3.879,all P<0.05).The term productivity of patients in group B was(53.7%)higher than that in group A(32.4%),while the abortion rate was(23.2%)lower than that in group A(41.7%)(x2=9.989,8.454,both P<0.05).The preterm birth rate of patients in the two groups was 25.9%and 23.2%.There was no significant difference(x2=0.104,P>0.05).Thrombocytopenia occurred in 7 patients in group A,accounting for 6.48%;Gingival bleeding occurred in 2 cases,accounting for 1.8%;There were 3 cases of ecchymosis(2.8%),and 11 cases of thrombocytopenia(10.2%)occurred in group B during treatment.Gingival bleeding occurred in 3 cases,accounting for 1.8%;There were 4 cases of ecchymosis,accounting for 3.70%.There was no significant statistical difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion The application of low molecular weight heparin in recurrent abortion can improve term productivity,reduce the abortion rate,increase the levels of estrogen and progesterone,and promote the improvement of coagulation function without increasing adverse reactions.

Low molecular weight heparinAbortion,habitualTreatment outcom

张赛男、李俊峰、白爱红、李荣香、付秀虹

展开 >

漯河市第一人民医院生殖医学与遗传中心,河南漯河 462300

低分子肝素 流产,习惯性 治疗结果

2024

中国药物与临床
中国医院协会

中国药物与临床

影响因子:0.846
ISSN:1671-2560
年,卷(期):2024.24(6)